» Articles » PMID: 12923151

Overweight and Obese Anovulatory Patients with Polycystic Ovaries: Parallel Improvements in Anthropometric Indices, Ovarian Physiology and Fertility Rate Induced by Diet

Overview
Journal Hum Reprod
Date 2003 Aug 19
PMID 12923151
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This prospective study evaluated the effect of weight reduction on anthropometric indices and ovarian morphology in anovulatory overweight patients with polycystic ovary syndrome (PCOS).

Methods: Thirty-three anovulatory overweight patients with PCOS were enrolled in the study. All had patent Fallopian tubes and chronic anovulation: 27 of them were oligo-amenorrhoeic. The partners were normospermic. Patients were prescribed a 1200 kcal/day diet, and physical exercise was recommended. Anthropometric indices and ovarian imaging parameters were assessed at baseline and after weight loss of 5 and 10%.

Results: Twenty-five patients (76%) lost at least 5% of their body weight. Eleven of these patients (33%) reached a 10% decrease in weight. Waist circumference at the umbilical level, hip circumference, four skin folds, body mass index and fatty mass ratio were significantly reduced after 5 and 10% weight loss. Ovarian morphology changed during the diet: we observed a significant reduction in ovarian volume and in the number of microfollicles per ovary. Among the 27 patients with oligo-amenorrhoea, 18 had a resumption of regular cycles and 15 experienced spontaneous ovulation; 10 spontaneous pregnancies occurred in patients who lost at least 5% of their weight.

Conclusions: Weight loss through a controlled low-calorie diet improves anthropometric indices in obese PCOS patients, reduces ovarian volume and microfollicle number and can restore ovulatory cycles, allowing spontaneous pregnancy.

Citing Articles

The association between age at menarche and infertility: a systematic review and meta-analysis of observational studies.

Moosazadeh M, Bordbari A, Hashemi S, Ghasemi Tirtashi M, Kargar-Soleimanabad S Contracept Reprod Med. 2025; 10(1):15.

PMID: 39994726 PMC: 11853611. DOI: 10.1186/s40834-025-00346-7.


Obesity and Polycystic Ovary Syndrome.

Kim J J Obes Metab Syndr. 2024; 33(4):289-301.

PMID: 39701598 PMC: 11704221. DOI: 10.7570/jomes24035.


Protocol for a randomized comparative effectiveness trial comparing a very low-carbohydrate diet to DASH diet for polycystic ovary syndrome: the SUPER (Supporting Understanding of PCOS Education and Research) trial.

Greenwell S, Jones A, Smith Y, Marriott D, Aikens J, Padmanabhan V Trials. 2024; 25(1):750.

PMID: 39516828 PMC: 11549875. DOI: 10.1186/s13063-024-08583-y.


Reproductive neuroendocrine defects programmed by prenatal testosterone treatment between gestational days 60-90 are amplified by postnatal obesity in sheep.

Gurule S, Sustaita-Monroe J, King L, Landers R, Garza V, West S Front Physiol. 2024; 15:1436954.

PMID: 39156826 PMC: 11327049. DOI: 10.3389/fphys.2024.1436954.


PRO-FIT-CARE study: the feasibility assessment of a pilot online exercise intervention for persons living with obesity and female infertility.

Wadden K, Hollohan N, Furneaux T, Maher R, Barrett C, Fuller D Front Sports Act Living. 2024; 6:1332376.

PMID: 38774277 PMC: 11107087. DOI: 10.3389/fspor.2024.1332376.